CD8A and infection: To this end, WT LCMV GP33 specific TCR transgenic CD8+/CD45.1+ T (P14) cells were adoptively transferred into CD45.1−/CD45.2+ WT and FAT-1 mice, followed by infection with LCMV for 7 days (Figure 4A).